BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A;  The Transplantation Society International CMV Consensus Group. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018;102:900-931. [PMID: 29596116 DOI: 10.1097/tp.0000000000002191] [Cited by in Crossref: 383] [Cited by in F6Publishing: 153] [Article Influence: 127.7] [Reference Citation Analysis]
Number Citing Articles
1 Deml L, Hüber CM, Barabas S, Spindler T, Cozzi E, Grossi P. Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens. Transplant Direct 2021;7:e781. [PMID: 34712781 DOI: 10.1097/TXD.0000000000001236] [Reference Citation Analysis]
2 Budde K, Halleck F. Risks and benefits of everolimus. Transpl Int 2019;32:1124-6. [PMID: 31397931 DOI: 10.1111/tri.13489] [Reference Citation Analysis]
3 Burkovsky L, Kahloan WM, Acharya A, Nair G, Conti RAS. A rare case of cytomegalovirus causing respiratory failure and a large pericardial effusion. J Community Hosp Intern Med Perspect 2021;11:693-7. [PMID: 34567467 DOI: 10.1080/20009666.2021.1954283] [Reference Citation Analysis]
4 Cheung A, Kwo P. Viral Hepatitis Other than A, B, and C: Evaluation and Management. Clin Liver Dis 2020;24:405-19. [PMID: 32620280 DOI: 10.1016/j.cld.2020.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Vazirani J, Crowhurst T, Morrissey CO, Snell GI. Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis. Infect Drug Resist 2021;14:5293-301. [PMID: 34916813 DOI: 10.2147/IDR.S301153] [Reference Citation Analysis]
6 Götting J, Lazar K, Suárez NM, Steinbrück L, Rabe T, Goelz R, Schulz TF, Davison AJ, Hamprecht K, Ganzenmueller T. Human Cytomegalovirus Genome Diversity in Longitudinally Collected Breast Milk Samples. Front Cell Infect Microbiol 2021;11:664247. [PMID: 33937103 DOI: 10.3389/fcimb.2021.664247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Parajuli S, Jorgenson M, Meyers RO, Djamali A, Galipeau J. Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients. Kidney360 2021;2:905-15. [DOI: 10.34067/kid.0001572021] [Reference Citation Analysis]
8 Kumru Sahin G, Eyupoglu S, Eren Sadioglu R, Cinar G, Ates K, Erturk S, Nergizoglu G, Sengul S, Kutlay S, Keven K. Cytomegalovirus infection in patients with glomerular diseases treated with cyclophosphamide: a single-center prospective study. Int Urol Nephrol 2021. [PMID: 34398345 DOI: 10.1007/s11255-021-02973-w] [Reference Citation Analysis]
9 Khurana MP, Lodding IP, Mocroft A, Sørensen SS, Perch M, Rasmussen A, Gustafsson F, Lundgren JD. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients. Open Forum Infect Dis 2019;6:ofz215. [PMID: 31211159 DOI: 10.1093/ofid/ofz215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
10 Anderson-Smits C, Baker ER, Hirji I. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature. Transpl Infect Dis 2020;22:e13396. [PMID: 32603496 DOI: 10.1111/tid.13396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Schreiber A, Elango K, Hong K, Ahsan C. Cardiac transplant recipient with COVID-19 induced acute hypoxic respiratory failure: a case report. Eur Heart J Case Rep 2021;5:ytab217. [PMID: 34189399 DOI: 10.1093/ehjcr/ytab217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 McLeroth P, Paduch DA, Abt M, Hughes R, Moore S, Mudie N. Effects of valganciclovir on spermatogenesis in renal transplant patients - results of a multicenter prospective nonrandomized study. Transpl Int 2020;33:310-20. [PMID: 31729770 DOI: 10.1111/tri.13558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fallahzadeh MA, Rico NT, Vahhab E, He H, Elhamahmi DA, Sandkovsky U. Strongyloides stercoralis and cytomegalovirus coinfection in a patient with a transplanted kidney. Baylor University Medical Center Proceedings 2022;35:190-2. [DOI: 10.1080/08998280.2021.1997262] [Reference Citation Analysis]
14 Terrec F, Jouve T, Malvezzi P, Janbon B, Naciri Bennani H, Rostaing L, Noble J. Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response. J Clin Med 2021;10:5159. [PMID: 34768680 DOI: 10.3390/jcm10215159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ortiz F, Lempinen M, Aaltonen S, Koivuviita N, Helanterä I. Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases. Clin Transplant 2021;:e14537. [PMID: 34797574 DOI: 10.1111/ctr.14537] [Reference Citation Analysis]
16 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
17 Kordzadeh-Kermani E, Khalili H, Karimzadeh I, Salehi M. Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators. Infect Drug Resist 2020;13:513-32. [PMID: 32110062 DOI: 10.2147/IDR.S233137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Hayden RT, Caliendo AM. Persistent Challenges of Interassay Variability in Transplant Viral Load Testing. J Clin Microbiol 2020;58:e00782-20. [PMID: 32554479 DOI: 10.1128/JCM.00782-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
19 Märtson AG, Touw D, Damman K, Bakker M, Oude Lansink-Hartgring A, van der Werf T, Knoester M, Alffenaar JC. Ganciclovir Therapeutic Drug Monitoring: A Case Series. Ther Drug Monit 2019;41:107-10. [PMID: 30883503 DOI: 10.1097/FTD.0000000000000598] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
20 Schaenman J, Phonphok K, Spanuchart I, Duong T, Sievers TM, Lum E, Reed EF, Bunnapradist S. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transpl Infect Dis 2021;23:e13457. [PMID: 32892447 DOI: 10.1111/tid.13457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Bruminhent J, Srisala S, Klinmalai C, Pinsai S, Watcharananan SP, Kantachuvesiri S, Hongeng S, Apiwattanakul N. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy. BMC Infect Dis 2019;19:974. [PMID: 31744480 DOI: 10.1186/s12879-019-4615-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Rump K, Rahmel T, Rustige AM, Unterberg M, Nowak H, Koos B, Schenker P, Viebahn R, Adamzik M, Bergmann L. The Aquaporin3 Promoter Polymorphism -1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell Migration. Cells 2020;9:E1421. [PMID: 32521638 DOI: 10.3390/cells9061421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Keskinoglu A, Bulut İK, Taner S, Turkes AZ, Kabasakal C. Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years' Time. Transplant Proc 2020;52:3186-91. [PMID: 32646585 DOI: 10.1016/j.transproceed.2020.03.023] [Reference Citation Analysis]
24 Nogueiras-álvarez R, Mora-cuesta V, Cifrián Martínez J, de Cos Cossío M, García Sáiz M. A Retrospective Review of Calcineurin Inhibitors’ Impact on Cytomegalovirus Infections in Lung Transplant Recipients. Transplantology 2021;2:478-90. [DOI: 10.3390/transplantology2040045] [Reference Citation Analysis]
25 Fida N, Tantrachoti P, Guha A, Bhimaraj A. Post-transplant Management in Heart Transplant Recipients: New Drugs and Prophylactic Strategies. Curr Treat Options Cardio Med 2021;23. [DOI: 10.1007/s11936-021-00933-2] [Reference Citation Analysis]
26 Solidoro P, Patrucco F, Boffini M, Rinaldi M, Airoldi C, Costa C, Cavallo R, Albera C. Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice. Ther Adv Respir Dis 2020;14:1753466620981851. [PMID: 33356914 DOI: 10.1177/1753466620981851] [Reference Citation Analysis]
27 Hemmersbach-Miller M, Wolfe CR, Schmader KE. Solid organ transplantation in older adults. Infectious and other age-related considerations. OBM Transplant 2019;3. [PMID: 34113803 DOI: 10.21926/obm.transplant.1901046] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Rahmel T, Nowak H, Rump K, Koos B, Schenker P, Viebahn R, Adamzik M, Bergmann L. The Aquaporin 5 -1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients. Front Immunol 2019;10:2871. [PMID: 31867018 DOI: 10.3389/fimmu.2019.02871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Hong YM, Min SY, Kim D, Kim S, Seo D, Lee KH, Han SH. Human MicroRNAs Attenuate the Expression of Immediate Early Proteins and HCMV Replication during Lytic and Latent Infection in Connection with Enhancement of Phosphorylated RelA/p65 (Serine 536) That Binds to MIEP. Int J Mol Sci 2022;23:2769. [PMID: 35269913 DOI: 10.3390/ijms23052769] [Reference Citation Analysis]
30 Chan S, Isbel NM, Hawley CM, Campbell SB, Campbell KL, Morrison M, Francis RS, Playford EG, Johnson DW. Infectious Complications Following Kidney Transplantation-A Focus on Hepatitis C Infection, Cytomegalovirus Infection and Novel Developments in the Gut Microbiota. Medicina (Kaunas) 2019;55:E672. [PMID: 31590269 DOI: 10.3390/medicina55100672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Ahlenstiel-Grunow T, Liu X, Schild R, Oh J, Taylan C, Weber LT, Staude H, Verboom M, Schröder C, Sabau R, Großhennig A, Pape L. Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial. J Am Soc Nephrol 2021;32:502-16. [PMID: 33323473 DOI: 10.1681/ASN.2020050645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Santhanakrishnan K, Yonan N, Iyer K, Callan P, Al-Aloul M, Venkateswaran R. Management of ganciclovir resistance cytomegalovirus infection with CMV hyperimmune globulin and leflunomide in seven cardiothoracic transplant recipients and literature review. Transpl Infect Dis 2021;:e13733. [PMID: 34534396 DOI: 10.1111/tid.13733] [Reference Citation Analysis]
33 Di Cristanziano V, Affeldt P, Trappe M, Wirtz M, Heger E, Knops E, Kaiser R, Stippel D, Müller RU, Holtick U, Scheid C, Kann M, Kurschat CE, Grundmann F. Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients. Microorganisms 2021;9:1666. [PMID: 34442744 DOI: 10.3390/microorganisms9081666] [Reference Citation Analysis]
34 Charlotte R, François P, Jonathan M, Véronique B, Olivier B, Tristan D, Séverine F, Jérôme L, Adrien T, Claire D, Espérie B, Eve C, Antoine R. Use of anti-CMV immunoglobulins in lung transplant recipients: The French experience. Transpl Infect Dis 2021;:e13754. [PMID: 34723405 DOI: 10.1111/tid.13754] [Reference Citation Analysis]
35 Limaye AP, Babu TM, Boeckh M. Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation. Clin Microbiol Rev 2020;34:e00043-19. [PMID: 33115722 DOI: 10.1128/CMR.00043-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
36 Bertrand D, Terrec F, Etienne I, Chavarot N, Sberro R, Gatault P, Garrouste C, Bouvier N, Grall-Jezequel A, Jaureguy M, Caillard S, Thervet E, Colosio C, Golbin L, Rerolle JP, Thierry A, Sayegh J, Janbon B, Malvezzi P, Jouve T, Rostaing L, Noble J. Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort. J Clin Med 2020;9:E3479. [PMID: 33126667 DOI: 10.3390/jcm9113479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Piret J, Boivin G. Antiviral Drugs Against Herpesviruses. Adv Exp Med Biol 2021;1322:1-30. [PMID: 34258735 DOI: 10.1007/978-981-16-0267-2_1] [Reference Citation Analysis]
38 Stern A, Papanicolaou GA. CMV Prevention and Treatment in Transplantation: What's New in 2019. Curr Infect Dis Rep 2019;21:45. [PMID: 31732823 DOI: 10.1007/s11908-019-0699-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
39 Parsons AJ, Ophir SI, Duty JA, Kraus TA, Stein KR, Moran TM, Tortorella D. Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH. Commun Biol 2022;5:387. [PMID: 35468974 DOI: 10.1038/s42003-022-03294-z] [Reference Citation Analysis]
40 Requião-Moura LR. Local evidence on the cytomegalovirus viral load threshold for preemptive treatment is welcome, and a comment on indirect effects. J Bras Nefrol 2021;43:457-9. [PMID: 34747434 DOI: 10.1590/2175-8239-JBN-2021-E009] [Reference Citation Analysis]
41 Majewska A, Mlynarczyk-Bonikowska B. 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs? Int J Mol Sci 2022;23:3431. [PMID: 35408788 DOI: 10.3390/ijms23073431] [Reference Citation Analysis]
42 Prohn M, Viberg A, Zhang D, Dykstra K, Davis C, Macha S, Sabato P, de Alwis D, Iwamoto M, Fancourt C, Cho CR. Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients. CPT Pharmacometrics Syst Pharmacol 2021;10:255-67. [PMID: 33440077 DOI: 10.1002/psp4.12593] [Reference Citation Analysis]
43 Rezzouk B, Bouattar T, Belkadi B, Razine R, Bayahia R, Ouzeddoun N, Benamar L, Rhou H, Bouihat N, Ibrahimi A, Seffar M, Kabbaj H. Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco. TRRM 2021;Volume 13:1-13. [DOI: 10.2147/trrm.s278655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Lérias JR, Paraschoudi G, Silva I, Martins J, de Sousa E, Condeço C, Figueiredo N, Carvalho C, Dodoo E, Jäger E, Rao M, Maeurer M. Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine. Int J Mol Sci 2019;20:E1986. [PMID: 31018546 DOI: 10.3390/ijms20081986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Limaye AP. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors. Clin Infect Dis 2021;73:e2739-45. [PMID: 32712663 DOI: 10.1093/cid/ciaa1051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Camargo JF, Pallikkuth S, Moroz I, Natori Y, Alcaide ML, Rodriguez A, Guerra G, Burke GW, Pahwa S. Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant Recipients. Kidney Int Rep 2019;4:1705-16. [PMID: 31844807 DOI: 10.1016/j.ekir.2019.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Otokubo M, Wada K, Ikura M, Hayase K, Uno T, Nakagita K, Hayakawa N, Watanabe T, Seguchi O, Fukushima N, Nakamura T. Risk Assessment of Neutropenia during Low-Dose Valganciclovir Prophylaxis for Heart Transplant Recipients. Biological & Pharmaceutical Bulletin 2022;45:452-9. [DOI: 10.1248/bpb.b21-00860] [Reference Citation Analysis]
48 El Helou G, Razonable RR. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infect Drug Resist 2019;12:1481-91. [PMID: 31239725 DOI: 10.2147/IDR.S180908] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
49 Ilic K, Song I, Wu J, Martin P. Evaluation of the Effect of Maribavir on Cardiac Repolarization in Healthy Participants: Thorough QT/QTc Study. Clin Transl Sci 2020;13:1260-70. [PMID: 32506738 DOI: 10.1111/cts.12814] [Reference Citation Analysis]
50 Hogan JI, Kotton CN. A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient. Open Forum Infect Dis 2021;8:ofab557. [PMID: 34988243 DOI: 10.1093/ofid/ofab557] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Kamar N, Lepage B, Couzi L, Albano L, Durrbach A, Pernin V, Esposito L, Hebral AL, Darres A, Lequintrec M, Cassuto E, Merville P, Congy N, Del Bello A. A Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients. Kidney Int Rep 2020;5:1207-17. [PMID: 32775820 DOI: 10.1016/j.ekir.2020.05.020] [Reference Citation Analysis]
52 Ciccocioppo R, Mengoli C, Betti E, Comolli G, Cassaniti I, Piralla A, Kruzliak P, Caprnda M, Pozzi L, Corazza GR, Di Sabatino A, Baldanti F. Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis. Clin Exp Med 2021;21:379-88. [PMID: 33772380 DOI: 10.1007/s10238-021-00702-2] [Reference Citation Analysis]
53 Yang SL, Lin TW, Lin HC, Wang HY, Chang PY, Wang PN, Yang S, Lu JJ. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan. J Microbiol Immunol Infect 2021;54:971-8. [PMID: 33632621 DOI: 10.1016/j.jmii.2021.01.007] [Reference Citation Analysis]
54 Zhang C, Wang YE, Miao H, Hou J. Efficacy and Safety of Aqueous Interleukin-8-Guided Treatment in Cytomegalovirus Retinitis after Bone Marrow Hematopoietic Stem Cell Transplantation. Ocul Immunol Inflamm 2020;:1-8. [PMID: 33064057 DOI: 10.1080/09273948.2020.1823422] [Reference Citation Analysis]
55 Pyöriä L, Jokinen M, Toppinen M, Salminen H, Vuorinen T, Hukkanen V, Schmotz C, Elbasani E, Ojala PM, Hedman K, Välimaa H, Perdomo MF. HERQ-9 Is a New Multiplex PCR for Differentiation and Quantification of All Nine Human Herpesviruses. mSphere 2020;5:e00265-20. [PMID: 32581076 DOI: 10.1128/mSphere.00265-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
56 Foster JG, Foster KJ. Care of the Renal Transplant Patient. Prim Care 2020;47:703-12. [PMID: 33121638 DOI: 10.1016/j.pop.2020.08.007] [Reference Citation Analysis]
57 Gliga S, Fiedler M, Dornieden T, Achterfeld A, Paul A, Horn PA, Herzer K, Lindemann M. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines (Basel) 2021;9:88. [PMID: 33504093 DOI: 10.3390/vaccines9020088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Kuo L, Tsai M, Kao J, Hu Y, Cheng C, Chang C, Roan J. Early cytomegalovirus reactivation after heart transplantation: A case report and literature review. Transplantation Reports 2021;6:100083. [DOI: 10.1016/j.tpr.2021.100083] [Reference Citation Analysis]
59 Rennie TJW, Petrie M, Metcalfe W, Walbaum D, Joss N, Barton E, Marson L, Clancy MJ, Henderson L, Traynor JP, Geddes CG, Phelan PJ. The impact of age on patient tolerance of mycophenolate following kidney transplantation. Nephrology (Carlton) 2020;25:566-74. [PMID: 32323461 DOI: 10.1111/nep.13718] [Reference Citation Analysis]
60 Baylis SA, Wallace P, McCulloch E, Niesters HGM, Nübling CM. Standardization of Nucleic Acid Tests: the Approach of the World Health Organization. J Clin Microbiol 2019;57:e01056-18. [PMID: 30257900 DOI: 10.1128/JCM.01056-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
61 Kandah E, Konda R, Kalantary A, Madadha A, Kunadi A. A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab. Cureus 2021;13:e14182. [PMID: 33936893 DOI: 10.7759/cureus.14182] [Reference Citation Analysis]
62 Paez-Vega A, Cantisan S, Vaquero JM, Vidal E, Luque-Pineda A, Lobo-Acosta MÁ, Pérez AB, Alonso-Moralejo R, Iturbe D, Monforte V, Otero-Gonzalez I, Pastor A, Ussetti P, Torre-Cisneros J. Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial. BMJ Open 2019;9:e030648. [PMID: 31420397 DOI: 10.1136/bmjopen-2019-030648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Teschner D, Knop J, Piehl C, Junker S, Witzke O. Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data. Infection 2022. [PMID: 35633464 DOI: 10.1007/s15010-022-01847-2] [Reference Citation Analysis]
64 Heldman MR, Aagaard KM, Hill JA. Assessing and restoring adaptive immunity to HSV, VZV and HHV-6 in solid organ and hematopoietic cell transplant recipients. Clin Microbiol Infect 2022:S1198-743X(22)00057-X. [PMID: 35150885 DOI: 10.1016/j.cmi.2022.02.001] [Reference Citation Analysis]
65 Tamura S, Osawa S, Ishida N, Miyazu T, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Kosugi I, Furuta T, Sugimoto K. Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis. Sci Rep 2021;11:13676. [PMID: 34211066 DOI: 10.1038/s41598-021-93168-x] [Reference Citation Analysis]
66 Bewarder M, Held G, Thurner L, Stilgenbauer S, Smola S, Preuss KD, Carbon G, Bette B, Christofyllakis K, Bittenbring JT, Felbel A, Hasse A, Murawski N, Kaddu-Mulindwa D, Neumann F. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential. Cancer Immunol Immunother 2020;69:1535-48. [PMID: 32300857 DOI: 10.1007/s00262-020-02564-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Pangonis S, Paulsen G, Andersen H, Flores F, Miethke A, Peters A, Kocoshis S, Lazear D, Garr B, Schecter M, Chin C, Hemmelgarn T, Danziger-Isakov L. Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation. Transpl Infect Dis 2020;22:e13232. [PMID: 31840369 DOI: 10.1111/tid.13232] [Reference Citation Analysis]
68 Han SH, Yoo SG, Do Han K, La Y, Kwon DE, Lee KH. The Incidence and Effect of Cytomegalovirus Disease on Mortality in Transplant Recipients and General Population: Real-world Nationwide Cohort Data. Int J Med Sci 2021;18:3333-41. [PMID: 34400903 DOI: 10.7150/ijms.62621] [Reference Citation Analysis]
69 Abbas A, Zimmer AJ, Florescu D. Viral Enteritis in Solid-Organ Transplantation. Viruses 2021;13:2019. [PMID: 34696449 DOI: 10.3390/v13102019] [Reference Citation Analysis]
70 Rohn H, Michita RT, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant. Cells 2019;8:E847. [PMID: 31394776 DOI: 10.3390/cells8080847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
71 La Y, Kwon DE, Yoo SG, Lee KH, Han SH, Song YG. Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea. BMC Infect Dis 2019;19:948. [PMID: 31703564 DOI: 10.1186/s12879-019-4607-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
72 Ganapathi L, Blumenthal J, Alawdah L, Lewis L, Gilarde J, Jones S, Milliren C, Kim HB, Sharma TS. Impact of standardized protocols for cytomegalovirus disease prevention in pediatric solid organ transplant recipients. Pediatr Transplant 2019;23:e13568. [PMID: 31515909 DOI: 10.1111/petr.13568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, Eason JD, Nouer SS, Sumida K, Remport A, Hall IE, Griffin R, Rofaiel G, Molnar MZ. CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors. Ren Fail 2022;44:831-41. [PMID: 35546431 DOI: 10.1080/0886022X.2022.2072744] [Reference Citation Analysis]
74 Imlay H, Dumitriu Carcoana AO, Fisher CE, Wong B, Rakita RM, Fishbein DP, Limaye AP. Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive/recipient seronegative heart transplant recipients. Transpl Infect Dis 2020;22:e13255. [PMID: 32020736 DOI: 10.1111/tid.13255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Laub MR, Byrns J, Gommer J, Ellis M, Harris M. Delayed vs initial cytomegalovirus prophylaxis after kidney transplantation. Clin Transplant 2020;34:e13854. [PMID: 32163619 DOI: 10.1111/ctr.13854] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Robinson C, Chanchlani R, Kitchlu A. Malignancies after pediatric solid organ transplantation. Pediatr Nephrol 2021;36:2279-91. [PMID: 33057766 DOI: 10.1007/s00467-020-04790-2] [Reference Citation Analysis]
77 Wetwittayakhlang P, Rujeerapaiboon N, Wetwittayakhlung P, Sripongpun P, Pruphetkaew N, Jandee S, Chamroonkul N, Piratvisuth T. Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients. Gastroenterol Res Pract 2021;2021:8886525. [PMID: 33897776 DOI: 10.1155/2021/8886525] [Reference Citation Analysis]
78 Morris MI, Muller E. Infectious Complications of Transplant Tourism. Curr Infect Dis Rep 2019;21:36. [PMID: 31473841 DOI: 10.1007/s11908-019-0696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Schubert L, Fisecker L, Thalhammer F, Burgmann H, Steininger C. Letermovir for the compassionate therapeutic use of cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2021;40:435-9. [PMID: 32914220 DOI: 10.1007/s10096-020-03990-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Al Mana H, Yassine HM, Younes NN, Al-Mohannadi A, Al-Sadeq DW, Alhababi D, Nasser EA, Nasrallah GK. The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review. Pathogens 2019;8:E213. [PMID: 31683687 DOI: 10.3390/pathogens8040213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
81 Jebakumar D, Bryant P, Linz W. Risk of cytomegalovirus transmission by blood products after solid organ transplantation. Proc (Bayl Univ Med Cent) 2019;32:222-6. [PMID: 31191133 DOI: 10.1080/08998280.2019.1582932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Rabbani N, Kronmal RA, Wagner T, Kemna M, Albers EL, Hong B, Friedland-Little J, Spencer K, Law YM. Association Between Cytomegalovirus Serostatus, Antiviral Therapy, and Allograft Survival in Pediatric Heart Transplantation. Transpl Int 2022;35:10121. [PMID: 35368645 DOI: 10.3389/ti.2022.10121] [Reference Citation Analysis]
83 Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M. Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study. J Clin Med 2019;8:E594. [PMID: 31052269 DOI: 10.3390/jcm8050594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
84 Gotta V, Leuppi-Taegtmeyer A, Gessler M, Pfister M, Müller D, Jehle AW. Intensive Hemodiafiltration Successfully Removes Ganciclovir Overdose and Largely Exceeds Reported Elimination During Hemodialysis-A Case Report and Review of the Literature. Front Pharmacol 2020;11:882. [PMID: 32595505 DOI: 10.3389/fphar.2020.00882] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Peng B, Gong H, Tian H, Zhuang Q, Li J, Cheng K, Ming Y. The study of the association between immune monitoring and pneumonia in kidney transplant recipients through machine learning models. J Transl Med. 2020;18:370. [PMID: 32993687 DOI: 10.1186/s12967-020-02542-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
86 Suárez Fernández ML, Ridao Cano N, Álvarez Santamarta L, Gago Fraile M, Blake O, Díaz Corte C. A Current Review of the Etiology, Clinical Features, and Diagnosis of Urinary Tract Infection in Renal Transplant Patients. Diagnostics (Basel) 2021;11:1456. [PMID: 34441390 DOI: 10.3390/diagnostics11081456] [Reference Citation Analysis]
87 Takagi Y, Miura K, Yabuuchi T, Kaneko N, Ishizuka K, Takei M, Yajima C, Ikeuchi Y, Kobayashi Y, Takizawa T, Hisano M, Tsurusaki Y, Matsumoto N, Hattori M. Any modality of renal replacement therapy can be a treatment option for Joubert syndrome. Sci Rep 2021;11:462. [PMID: 33432080 DOI: 10.1038/s41598-020-80712-4] [Reference Citation Analysis]
88 Tsai HP, Yeh CS, Lin IT, Ko WC, Wang JR. Increasing Cytomegalovirus Detection Rate from Respiratory Tract Specimens by a New Laboratory-Developed Automated Molecular Diagnostic Test. Microorganisms 2020;8:E1063. [PMID: 32708818 DOI: 10.3390/microorganisms8071063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Yoon M, Oh J, Chun KH, Lee CJ, Kang SM. Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation. Sci Rep 2021;11:1426. [PMID: 33446808 DOI: 10.1038/s41598-020-80790-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
90 Wiening V, Schmidt T, Dahmen M, Siam S, Reuter S, Pavenstädt HJ, Sester M, Suwelack B. Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity. Front Immunol 2020;11:623178. [PMID: 33569064 DOI: 10.3389/fimmu.2020.623178] [Reference Citation Analysis]
91 Law JP, Borrows R, McNulty D, Sharif A, Ferro CJ. Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients. BMC Nephrol 2021;22:102. [PMID: 33743617 DOI: 10.1186/s12882-021-02285-2] [Reference Citation Analysis]
92 Cohen-Bucay A, Gordon CE, Francis JM. Non-immunological complications following kidney transplantation. F1000Res. 2019;8. [PMID: 30828430 DOI: 10.12688/f1000research.16627.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
93 Haidar G, Boeckh M, Singh N. Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence. J Infect Dis 2020;221:S23-31. [PMID: 32134486 DOI: 10.1093/infdis/jiz454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
94 Scarpini S, Morigi F, Betti L, Dondi A, Biagi C, Lanari M. Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice. Vaccines (Basel) 2021;9:551. [PMID: 34070277 DOI: 10.3390/vaccines9060551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Franck B, Autmizguine J, Marquet P, Ovetchkine P, Woillard JB. Pharmacokinetics, Pharmacodynamics, and Therapeutic Drug Monitoring of Valganciclovir and Ganciclovir in Transplantation. Clin Pharmacol Ther 2021. [PMID: 34596243 DOI: 10.1002/cpt.2431] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ahn B, Yun KW, Hong KT, Choi JY, Kang HJ, Seong MW, Kim TS, Ahn SJ, Choi EH. Threshold of Quantitative Cytomegalovirus DNA PCR for Preemptive Treatment in Pediatric Hematopoietic Stem Cell Transplant Recipients. J Pediatr Hematol Oncol 2022. [PMID: 35482472 DOI: 10.1097/MPH.0000000000002467] [Reference Citation Analysis]
97 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Reference Citation Analysis]
98 Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in Viral Infections in the Intensive Care Unit. Front Med (Lausanne) 2021;8:575580. [PMID: 33708775 DOI: 10.3389/fmed.2021.575580] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Lazzarotto T, Chiereghin A, Piralla A, Gibertoni D, Piccirilli G, Turello G, Campanini G, Gabrielli L, Costa C, Comai G, La Manna G, Biancone L, Rampino T, Gregorini M, Sidoti F, Bianco G, Mauro MV, Greco F, Cavallo R, Baldanti F; AMCLI-GLaIT. Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies. PLoS One 2020;15:e0238062. [PMID: 32841308 DOI: 10.1371/journal.pone.0238062] [Reference Citation Analysis]
100 Pellett Madan R, Allen UD, Green M, Höcker B, Michaels MG, Varela-Fascinetto G, Danziger-Isakov L; Pediatric Subgroup for the International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation and the International Pediatric Transplant Association Infectious Disease Committee. Pediatric transplantation case conference: Update on cytomegalovirus. Pediatr Transplant 2018;22:e13276. [PMID: 30203626 DOI: 10.1111/petr.13276] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
101 Dvořáčková E, Šíma M, Petrus J, Klapková E, Hubáček P, Pozniak J, Havlín J, Lischke R, Slanař O. Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics 2022;14:408. [DOI: 10.3390/pharmaceutics14020408] [Reference Citation Analysis]
102 Jorgenson MR, Parajuli S, Marka N, Leverson GE, Smith JA, Mandelbrot DA, Odorico JS. Geographic Distribution of Cytomegalovirus Serology in Kidney and Pancreas Transplant Recipients in the United States. Transplant Direct 2021;7:e704. [PMID: 34056079 DOI: 10.1097/TXD.0000000000001147] [Reference Citation Analysis]
103 Jorgenson MR, Kleiboeker H, Garg N, Parajuli S, Mandelbrot DA, Odorico JS, Saddler CM, Smith JA. Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunity. Transpl Infect Dis 2021;:e13766. [PMID: 34799964 DOI: 10.1111/tid.13766] [Reference Citation Analysis]
104 Jaksic Jurinjak S, Hulak V, Udovicic M. Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure. SAGE Open Med Case Rep 2021;9:2050313X21989496. [PMID: 33796306 DOI: 10.1177/2050313X21989496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Ramendra R, Isnard S, Lin J, Fombuena B, Ouyang J, Mehraj V, Zhang Y, Finkelman M, Costiniuk C, Lebouché B, Chartrand-Lefebvre C, Durand M, Tremblay C, Ancuta P, Boivin G, Routy JP. Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls. Clin Infect Dis 2020;71:1438-46. [PMID: 31608409 DOI: 10.1093/cid/ciz1001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
106 Touma J, Liu Y, Rahbar A, Pantalone MR, Almazan NM, Vetvik K, Söderberg-Nauclér C, Geisler J, Sauer T. Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens-A Novel, Automated Immunohistochemical Staining Protocol. Microorganisms 2021;9:1059. [PMID: 34068349 DOI: 10.3390/microorganisms9051059] [Reference Citation Analysis]
107 Jehn U, Schütte-Nütgen K, Bautz J, Pavenstädt H, Suwelack B, Thölking G, Reuter S. Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation. Sci Rep 2020;10:22406. [PMID: 33376243 DOI: 10.1038/s41598-020-79799-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Bayrak NA, Polat E, Erdogan F. Cytomegalovirus Colitis in Immunocompetent and Immunocompromised Children: A 2-Center Study. Pediatr Infect Dis J 2021;40:1101-7. [PMID: 34609104 DOI: 10.1097/INF.0000000000003339] [Reference Citation Analysis]
109 Ivana T, Robert P, Pavel S, Lenka T, Irena K. Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells. Transpl Immunol 2022;:101539. [PMID: 35051589 DOI: 10.1016/j.trim.2022.101539] [Reference Citation Analysis]
110 Hemmersbach-Miller M, Alexander BD, Pieper CF, Schmader KE. Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient. Eur J Clin Microbiol Infect Dis 2020;39:455-63. [PMID: 31758441 DOI: 10.1007/s10096-019-03744-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
111 Li S, Shen ZH, Wan LP, Bao AH, Yang J, Tong Y, Wang C. [Clinical study of 34 patients with cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2020;41:843-7. [PMID: 33190442 DOI: 10.3760/cma.j.issn.0253-2727.2020.10.009] [Reference Citation Analysis]
112 Lease ED, Budev MM. Infectious Complications in Lung Transplant Recipients. Thorac Surg Clin 2022;32:211-20. [PMID: 35512939 DOI: 10.1016/j.thorsurg.2021.12.002] [Reference Citation Analysis]
113 Maertens J, Lyon S. Optimizing the management of cytomegalovirus infection in transplant patients. Future Virology 2018;13:765-8. [DOI: 10.2217/fvl-2018-0142] [Reference Citation Analysis]
114 Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H, Shimizu M, Tanaka T, Hara A. Virus-Driven Carcinogenesis. Cancers (Basel) 2021;13:2625. [PMID: 34071792 DOI: 10.3390/cancers13112625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Ju CR, Lian QY, Zhang JH, Qiu T, Cai ZT, Jiang WY, Zhang J, Cheng Q, Chen G, Li N, Wang CY, He JX. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med 2020;6:87-97. [PMID: 32363045 DOI: 10.1016/j.cdtm.2020.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
116 Houldcroft CJ, Jackson SE, Lim EY, Sedikides GX, Davies EL, Atkinson C, McIntosh M, Remmerswaal EBM, Okecha G, Bemelman FJ, Stanton RJ, Reeves M, Wills MR. Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay. Front Cell Infect Microbiol 2020;10:275. [PMID: 32670891 DOI: 10.3389/fcimb.2020.00275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Mullane KM. Human Cytomegalovirus Prophylaxis and Treatment in Lung Transplantation in the Current Era. Curr Pulmonol Rep 2020;9:10-27. [DOI: 10.1007/s13665-020-00246-y] [Reference Citation Analysis]
118 Walti LN, Mugglin C, Sidler D, Mombelli M, Manuel O, Hirsch HH, Khanna N, Mueller N, Berger C, Boggian K, Garzoni C, Neofytos D, van Delden C, Hirzel C; Swiss Transplant Cohort Study (STCS). Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study. Am J Transplant 2021;21:2532-42. [PMID: 33289340 DOI: 10.1111/ajt.16423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
119 Chou S, Wu J, Song K, Bo T. Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection. Antiviral Res 2019;172:104616. [PMID: 31568799 DOI: 10.1016/j.antiviral.2019.104616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
120 Van Leer Buter CC, de Voogd DWK, Blokzijl H, de Joode AAE, Berger SP, Verschuuren EAM, Niesters HGM. Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands. J Antimicrob Chemother 2019;74:2370-6. [PMID: 31093660 DOI: 10.1093/jac/dkz196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Chamoun B, Torres IB, Gabaldón A, Sellarés J, Perelló M, Castellá E, Guri X, Salcedo M, Toapanta NG, Cidraque I, Moreso F, Seron D. Progression of Interstitial Fibrosis and Tubular Atrophy in Low Immunological Risk Renal Transplants Monitored by Sequential Surveillance Biopsies: The Influence of TAC Exposure and Metabolism. J Clin Med 2021;10:E141. [PMID: 33406589 DOI: 10.3390/jcm10010141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Aziz F, Djamali A. Post-Transplant CMV Glomerulitis. Clin J Am Soc Nephrol 2021;16:957-9. [PMID: 33568381 DOI: 10.2215/CJN.19061220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Da Cunha T, Wu GY. Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts. J Clin Transl Hepatol 2021;9:106-15. [PMID: 33604261 DOI: 10.14218/JCTH.2020.00088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Grigore M, Iordache M, Bănică C, Ioniţă-radu F, Jinga M, Bucurică S. Prolonged Febrile Syndrome in a Patient with Inflammatory Bowel Disease. Internal Medicine 2022;19:107-14. [DOI: 10.2478/inmed-2022-0202] [Reference Citation Analysis]
125 Nagarajah S, Rasmussen M, Hoegh SV, Tepel M. Prospective Study of Long Noncoding RNA, MGAT3-AS1, and Viremia of BK Polyomavirus and Cytomegalovirus in Living Donor Renal Transplant Recipients. Kidney Int Rep 2020;5:2218-27. [PMID: 33305115 DOI: 10.1016/j.ekir.2020.09.005] [Reference Citation Analysis]
126 Boonsathorn S, Pasomsub E, Techasaensiri C, Apiwattanakul N. Analysis of Ganciclovir-Resistant Cytomegalovirus Infection Caused by the UL97 Gene Mutation in Codons 460 and 520 in Pediatric Patients: A Case Series. Open Forum Infect Dis 2019;6:ofz480. [PMID: 32528998 DOI: 10.1093/ofid/ofz480] [Reference Citation Analysis]
127 Noble J, Maniere L, Pernollet M, Jacob MC, Germi R, Chevallier E, Rostaing L. Baseline anti-CMV cellular immunity is similar between patients with a kidney transplant or receiving hemodialysis. Transpl Int 2020;33:961-2. [PMID: 32311202 DOI: 10.1111/tri.13620] [Reference Citation Analysis]
128 Igbinedion SO, Patel K, Samant H, Wellman GP. Ganciclovir-Resistant CMV Colitis in a Donor-Seronegative/Recipient-Seronegative Liver Transplant Patient. ACG Case Rep J 2018;5:e102. [PMID: 30643845 DOI: 10.14309/crj.2018.102] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Cheng WY, Avery RK, Thompson-Leduc P, Cheung HC, Bo T, Duh MS, Hirji I. Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation. J Med Econ 2022;:1-39. [PMID: 35240904 DOI: 10.1080/13696998.2022.2046388] [Reference Citation Analysis]
130 Carvalho-Gomes Â, Cubells A, Pallarés C, Corpas-Burgos F, Berenguer M, Aguilera V, López-Labrador FX. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation. Cell Immunol 2021;371:104455. [PMID: 34864514 DOI: 10.1016/j.cellimm.2021.104455] [Reference Citation Analysis]
131 Cherrier L, Nasar A, Goodlet KJ, Nailor MD, Tokman S, Chou S. Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection. Am J Transplant 2018;18:3060-4. [PMID: 30286286 DOI: 10.1111/ajt.15135] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 17.3] [Reference Citation Analysis]
132 Wong DD, van Zuylen WJ, Novos T, Stocker S, Reuter SE, Au J, Foster CSP, Day RO, Horvath AR, Endre Z, Rawlinson WD. Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis. Microbiol Spectr 2022;:e0268421. [PMID: 35658598 DOI: 10.1128/spectrum.02684-21] [Reference Citation Analysis]
133 Lindemann M, Korth J, Sun M, Xu S, Struve C, Werner K, Dornieden T, Horn PA, Witzke O, Wilde B. The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients. Int J Mol Sci 2018;19:E3945. [PMID: 30544783 DOI: 10.3390/ijms19123945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
134 Kim YE, Choi HJ, Lee HJ, Oh HJ, Ahn MK, Oh SH, Namgoong JM, Kim DY, Jhang WK, Park SJ, Jung DH, Moon DB, Song GW, Park GC, Ha TY, Ahn CS, Kim KH, Hwang S, Lee SG, Kim KM. Assessment of pathogens and risk factors associated with bloodstream infection in the year after pediatric liver transplantation. World J Gastroenterol 2022; 28(11): 1159-1171 [DOI: 10.3748/wjg.v28.i11.1159] [Reference Citation Analysis]
135 Weiler N, Trötschler S, Vermehren J, Schnitzbauer AA, Bechstein WO, Herrmann E, Zeuzem S, Welker M. Risk-guided strategy to prevent cytomegalovirus associated complications after liver transplantation. Future Virology 2018;13:483-91. [DOI: 10.2217/fvl-2018-0045] [Reference Citation Analysis]
136 Hellemans R, Wijtvliet V, Bergs K, Philipse E, Vleut R, Massart A, Couttenye MM, Matheeussen V, Abramowicz D. A split strategy to prevent cytomegalovirus after kidney transplantation using prophylaxis in serological high-risk patients and a pre-emptive strategy in intermediate-risk patients: Combining the best of two options? Transpl Infect Dis 2021;23:e13467. [PMID: 32935909 DOI: 10.1111/tid.13467] [Reference Citation Analysis]
137 Gatz JD, Spangler R. Evaluation of the Renal Transplant Recipient in the Emergency Department. Emerg Med Clin North Am 2019;37:679-705. [PMID: 31563202 DOI: 10.1016/j.emc.2019.07.008] [Reference Citation Analysis]
138 Otto WR, Green A. Antiviral Therapeutics in Pediatric Transplant Recipients. Infectious Disease Clinics of North America 2022;36:125-46. [DOI: 10.1016/j.idc.2021.11.004] [Reference Citation Analysis]
139 Maupoey Ibáñez J, Boscà Robledo A, López-Andujar R. Late complications of pancreas transplant. World J Transplant 2020; 10(12): 404-414 [PMID: 33437673 DOI: 10.5500/wjt.v10.i12.404] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Neuberger J. Immunosuppression in gastroenterology and hepatology. Best Pract Res Clin Gastroenterol 2021;54-55:101758. [PMID: 34874842 DOI: 10.1016/j.bpg.2021.101758] [Reference Citation Analysis]
141 Zhang Z, Qiu L, Yan S, Wang JJ, Thomas PM, Kandpal M, Zhao L, Iovane A, Liu XF, Thorp EB, Chen Q, Hummel M, Kanwar YS, Abecassis MM. A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant. Am J Transplant 2019;19:2421-33. [PMID: 30947382 DOI: 10.1111/ajt.15376] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
142 Alfieri CM, Molinari P, Gandolfo M, Campise M, Cresseri D, Regalia A, Favi E, Li M, Ikehata M, Delbue S, Messa P. Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients Outcomes. Pathogens 2021;10:473. [PMID: 33919676 DOI: 10.3390/pathogens10040473] [Reference Citation Analysis]
143 Mehta K, Al‐yabes O, Allen A, Williams A, Petrich A, Langlois V, Hébert D, Allen U. Burden of cytomegalovirus DNAemia among pediatric renal transplant patients on antiviral prophylaxis: A hospital‐based analysis. Pediatr Transplant 2020;24. [DOI: 10.1111/petr.13650] [Reference Citation Analysis]
144 Laporta Hernandez R, Aguilar Perez M, Lázaro Carrasco MT, Ussetti Gil P. Lung Transplantation in Idiopathic Pulmonary Fibrosis. Med Sci (Basel) 2018;6:E68. [PMID: 30142942 DOI: 10.3390/medsci6030068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Yoo SG, Han KD, Lee KH, La Y, Kwon DE, Han SH. Impact of Cytomegalovirus Disease on New-Onset Type 2 Diabetes Mellitus: Population-Based Matched Case-Control Cohort Study. Diabetes Metab J 2019;43:815-29. [PMID: 30688050 DOI: 10.4093/dmj.2018.0167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
146 Dorsey YC, Oloruntoba O, Pendse AA, King LY. More Than Meets the Eye? Clin Liver Dis (Hoboken) 2021;18:173-8. [PMID: 34745573 DOI: 10.1002/cld.1107] [Reference Citation Analysis]
147 Roberts SC, Ison MG. Donor-Derived Disease Transmission in Lung Transplantation. Curr Pulmonol Rep 2020;9:1-9. [DOI: 10.1007/s13665-020-00245-z] [Reference Citation Analysis]
148 Luyt CE, Forel JM, Hajage D, Jaber S, Cayot-Constantin S, Rimmelé T, Coupez E, Lu Q, Diallo MH, Penot-Ragon C, Clavel M, Schwebel C, Timsit JF, Bedos JP, Hauw-Berlemont C, Bourenne J, Mayaux J, Lefrant JY, Mira JP, Combes A, Wolff M, Chastre J, Papazian L; Preemptive Treatment for Herpesviridae Study Group, Réseau Européen de recherche en Ventilation Artificielle Network. Acyclovir for Mechanically Ventilated Patients With Herpes Simplex Virus Oropharyngeal Reactivation: A Randomized Clinical Trial. JAMA Intern Med 2020;180:263-72. [PMID: 31841577 DOI: 10.1001/jamainternmed.2019.5713] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
149 Multani A, Allard LS, Wangjam T, Sica RA, Epstein DJ, Rezvani AR, Ho DY. Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study. Blood Adv 2019;3:3602-12. [PMID: 31743391 DOI: 10.1182/bloodadvances.2019000634] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
150 Rosenzweig M, Wall A, Spak CW, Testa G, Johannesson L. Pregnancy after CMV infection following uterus transplantation: A case report from the Dallas Uterus Transplant Study. Transpl Infect Dis 2021;23:e13653. [PMID: 34038016 DOI: 10.1111/tid.13653] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
151 Solidoro P, Patrucco F, Libertucci D, Verri G, Sidoti F, Curtoni A, Boffini M, Simonato E, Rinaldi M, Cavallo R, Costa C. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis. Ther Adv Respir Dis 2019;13:1753466619878555. [PMID: 31566097 DOI: 10.1177/1753466619878555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Manière L, Noble J, Terrec F, Bennani HN, Chevallier E, Janbon B, Germi R, Bugnazet M, Imerzoukene F, Malvezzi P, Rostaing L, Jouve T. Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis. Int Urol Nephrol 2021;53:591-600. [PMID: 33058036 DOI: 10.1007/s11255-020-02676-8] [Reference Citation Analysis]
153 Prohaska S, Henn P, Wenz S, Frauenfeld L, Rosenberger P, Haeberle HA. A case report of fatal disseminated fungal sepsis in a patient with ARDS and extracorporeal membrane oxygenation. BMC Anesthesiol 2020;20:107. [PMID: 32381041 DOI: 10.1186/s12871-020-01031-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Hemmersbach-Miller M, Alexander BD, Sudan DL, Pieper C, Schmader KE. Infections after kidney transplantation. Does age matter? Clin Transplant 2019;33:e13516. [PMID: 30849194 DOI: 10.1111/ctr.13516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
155 Bruminhent J, Bushyakanist A, Kantachuvesiri S, Kiertiburanakul S. A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting. Open Forum Infect Dis 2019;6:ofz322. [PMID: 31660402 DOI: 10.1093/ofid/ofz322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
156 Jothimani D, Venugopal R, Vij M, Rela M. Post liver transplant recurrent and de novo viral infections. Best Pract Res Clin Gastroenterol. 2020;46-47:101689. [PMID: 33158469 DOI: 10.1016/j.bpg.2020.101689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
157 Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis 2019;68:1420-6. [PMID: 30137245 DOI: 10.1093/cid/ciy696] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 26.0] [Reference Citation Analysis]
158 Kornberg A, Witt U, Kornberg J, Müller K, Friess H, Thrum K. Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival. J Clin Med 2020;9:E656. [PMID: 32121313 DOI: 10.3390/jcm9030656] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Yang QH, Ma XP, Dai DL, Bai DM, Zou Y, Liu SX, Song JM. Gastrointestinal cytomegalovirus disease secondary to measles in an immunocompetent infant: A case report. World J Gastroenterol 2021; 27(15): 1655-1663 [PMID: 33958850 DOI: 10.3748/wjg.v27.i15.1655] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Lin H, Chen L, Wen S, Yue Z, Mo Y, Jiang X, Huang L. Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review. Ren Fail 2020;42:776-84. [PMID: 32757688 DOI: 10.1080/0886022X.2020.1800491] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Gardiner BJ, Lee SJ, Robertson AN, Cristiano Y, Snell GI, Morrissey CO, Peleg AY, Westall GP. Real-world experience of Quantiferon®-CMV directed prophylaxis in lung transplant recipients. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.05.004] [Reference Citation Analysis]
162 Sise ME, Goldberg DS, Schaubel DE, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Blumberg EA, Woodle ES, Sherman KE, Brown RS, Friedewald JJ, Desai NM, Sultan ST, Levitsky J, Lee MD, Strohbehn IA, Landis JR, Fernando M, Gustafson JL, Chung RT, Reese PP. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial. Kidney International Reports 2022;7:241-50. [DOI: 10.1016/j.ekir.2021.11.022] [Reference Citation Analysis]
163 Märtson AG, Edwina AE, Burgerhof JGM, Berger SP, de Joode A, Damman K, Verschuuren EAM, Blokzijl H, Bakker M, Span LF, van der Werf TS, Touw DJ, Sturkenboom MGG, Knoester M, Alffenaar JWC. Ganciclovir therapeutic drug monitoring in transplant recipients. J Antimicrob Chemother 2021:dkab195. [PMID: 34160036 DOI: 10.1093/jac/dkab195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol 2021. [PMID: 34168328 DOI: 10.1038/s41579-021-00582-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
165 Kwon DE, Lee HS, Lee KH, La Y, Han SH, Song YG. Incidence of herpes zoster in adult solid organ transplant recipients: A meta-analysis and comprehensive review. Transpl Infect Dis 2021;23:e13674. [PMID: 34153168 DOI: 10.1111/tid.13674] [Reference Citation Analysis]
166 Gandhi RG, Kotton CN. Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus. TCRM 2022;Volume 18:223-32. [DOI: 10.2147/tcrm.s303052] [Reference Citation Analysis]
167 Prakash K, Chandorkar A, Saharia KK. Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update. Diagnostics (Basel) 2021;11:875. [PMID: 34068377 DOI: 10.3390/diagnostics11050875] [Reference Citation Analysis]
168 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
169 Griffiths P, Hughes B. Choice of Study Populations for Vaccines. J Infect Dis 2020;221:S128-34. [PMID: 32134487 DOI: 10.1093/infdis/jiz537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
170 Hall VG, Humar A, Kumar D. Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation. J Clin Microbiol 2022;:e0171621. [PMID: 35543099 DOI: 10.1128/jcm.01716-21] [Reference Citation Analysis]
171 Saeed H, Thoendel M, Razonable RR. Individualized management of cytomegalovirus in solid organ transplant recipients. Expert Review of Precision Medicine and Drug Development 2021;6:333-44. [DOI: 10.1080/23808993.2021.1964951] [Reference Citation Analysis]
172 Saullo JL, Baker AW, Snyder LD, Reynolds JM, Zaffiri L, Eichenberger EM, Ferrari A, Steinbrink JM, Maziarz EK, Bacchus M, Berry H, Kakoullis SA, Wolfe CR. Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis. J Heart Lung Transplant 2021:S1053-2498(21)02626-7. [PMID: 35031206 DOI: 10.1016/j.healun.2021.12.005] [Reference Citation Analysis]
173 Deborska-Materkowska D, Perkowska-Ptasinska A, Sadowska-Jakubowicz A, Gozdowska J, Ciszek M, Pazik J, Ostaszewska A, Kosieradzki M, Nowak J, Durlik M. Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients. Int J Mol Sci 2019;20:E546. [PMID: 30696053 DOI: 10.3390/ijms20030546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
174 Struble EB, Murata H, Komatsu T, Scott D. Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection. Int J Mol Sci 2021;22:8728. [PMID: 34445434 DOI: 10.3390/ijms22168728] [Reference Citation Analysis]
175 Harris TN, Szempruch KR, Dupuis RE, Serrano Rodriguez P, Toledo AH. Alemtuzumab in Renal Retransplantation - Transplant Outcomes and Associated Infections. Transplant Proc 2021:S0041-1345(21)00716-8. [PMID: 34774310 DOI: 10.1016/j.transproceed.2021.08.056] [Reference Citation Analysis]
176 Santos Bravo M, Tilloy V, Plault N, Palomino SS, Mosquera MM, Navarro Gabriel M, Fernández Avilés F, Suárez Lledó M, Rovira M, Moreno A, Linares L, Bodro M, Hantz S, Alain S, Marcos MÁ. Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients. Microbiol Spectr 2022;:e0019122. [PMID: 35343771 DOI: 10.1128/spectrum.00191-22] [Reference Citation Analysis]
177 Clausen ES, Zaffiri L. Infection prophylaxis and management of viral infection. Ann Transl Med 2020;8:415. [PMID: 32355859 DOI: 10.21037/atm.2019.11.85] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
178 Blazquez-Navarro A, Dang-Heine C, Bauer C, Wittenbrink N, Wolk K, Sabat R, Witzke O, Westhoff TH, Sawitzki B, Reinke P, Thomusch O, Hugo C, Babel N, Or-Guil M. Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients. Front Pharmacol 2020;11:534681. [PMID: 33519427 DOI: 10.3389/fphar.2020.534681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
179 Ribeiro RVP, Ku T, Wang A, Pires L, Ferreira VH, Michaelsen V, Ali A, Galasso M, Moshkelgosha S, Gazzalle A, Jeppesen MG, Rosenkilde MM, Liu M, Singer LG, Kumar D, Keshavjee S, Sinclair J, Kledal TN, Humar A, Cypel M. Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin. J Heart Lung Transplant 2021:S1053-2498(21)02544-4. [PMID: 34802874 DOI: 10.1016/j.healun.2021.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Lima AS, Pereira BB, Jungmann S, Machado CJ, Correia MITD. RISK FACTORS FOR POST-LIVER TRANSPLANT BILIARY COMPLICATIONS IN THE ABSENCE OF ARTERIAL COMPLICATIONS. Arq Bras Cir Dig 2020;33:e1541. [PMID: 33331436 DOI: 10.1590/0102-672020200003e1541] [Reference Citation Analysis]
181 Marx S, Adam C, Mihm J, Weyrich M, Sester U, Sester M. A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis. Front Immunol 2020;11:916. [PMID: 32499781 DOI: 10.3389/fimmu.2020.00916] [Reference Citation Analysis]
182 Raghu VK, Vetterly CG, Horslen SP. Immunosuppression Regimens for Intestinal Transplantation in Children. Pediatr Drugs. [DOI: 10.1007/s40272-022-00512-3] [Reference Citation Analysis]
183 Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract 2018;37:323-37. [PMID: 30619688 DOI: 10.23876/j.krcp.18.0063] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
184 Hunt J, Chapple KM, Nasar A, Cherrier L, Walia R. Efficacy of low-dose valganciclovir in CMV R+ lung transplant recipients: a retrospective comparative analysis. Multidiscip Respir Med 2021;16:706. [PMID: 33569173 DOI: 10.4081/mrm.2021.706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Morel A, Hoisnard L, Dudreuilh C, Moktefi A, Kheav D, Pimentel A, Sakhi H, Mokrani D, Attias P, El Sakhawi K, Champy CM, Remy P, Sbidian E, Grimbert P, Matignon M. Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy. Transpl Int 2022;35:10228. [PMID: 35497889 DOI: 10.3389/ti.2022.10228] [Reference Citation Analysis]
186 Stadnik CMB, Caurio CFB, Rodrigues-Filho EM, Nedel WL, Cantisani GP, Zanotelli ML, Pasqualotto AC. Impact of cytomegalovirus reactivation just before liver transplantation: A prospective cohort study. World J Gastrointest Pathophysiol 2021; 12(3): 51-58 [PMID: 34084592 DOI: 10.4291/wjgp.v12.i3.51] [Reference Citation Analysis]
187 Srivastava A, Bodnar J, Osman F, Jorgenson MR, Astor BC, Mandelbrot DA, Parajuli S. Serum Albumin Level Before Kidney Transplant Predicts Post-transplant BK and Possibly Cytomegalovirus Infection. Kidney Int Rep 2020;5:2228-37. [PMID: 33305116 DOI: 10.1016/j.ekir.2020.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Chiereghin A, Verucchi G, Lazzarotto T. CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature. Viruses 2021;13:816. [PMID: 34062875 DOI: 10.3390/v13050816] [Reference Citation Analysis]
189 Schildermans J, De Vlieger G. Cytomegalovirus: A Troll in the ICU? Overview of the Literature and Perspectives for the Future. Front Med (Lausanne) 2020;7:188. [PMID: 32500076 DOI: 10.3389/fmed.2020.00188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
190 Fronek J, Kristek J, Chlupac J, Janousek L, Olausson M. Human Uterus Transplantation from Living and Deceased Donors: The Interim Results of the First 10 Cases of the Czech Trial. J Clin Med 2021;10:586. [PMID: 33557282 DOI: 10.3390/jcm10040586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
191 Mazzola P, Schaeffeler E, Witzke O, Nitschke M, Kliem V, Zortel M, Wagner EM, Schwab M, Hauser IA. No association of genetic variants in TLR4, TNF-α, IL10, IFN-γ, and IL37 in cytomegalovirus-positive renal allograft recipients with active CMV infection-Subanalysis of the prospective randomised VIPP study. PLoS One 2021;16:e0246118. [PMID: 33861738 DOI: 10.1371/journal.pone.0246118] [Reference Citation Analysis]
192 Engelmann C, Sterneck M, Weiss KH, Templin S, Zopf S, Denk G, Eurich D, Pratschke J, Weiss J, Braun F, Welker MW, Zimmermann T, Knipper P, Nierhoff D, Lorf T, Jäckel E, Hau HM, Tsui TY, Perrakis A, Schlitt HJ, Herzer K, Tacke F. Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers. J Clin Med 2020;9:E2352. [PMID: 32717978 DOI: 10.3390/jcm9082352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
193 Paolucci S, Campanini G, Cassaniti I, Tebaldi A, Novazzi F, Fratini A, Meini A, Girelli F, Palumbo L, Plebani A, Baldanti F. Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report. BMC Infect Dis 2021;21:994. [PMID: 34556034 DOI: 10.1186/s12879-021-06694-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Jorgenson MR, Descourouez JL, Astor BC, Smith JA, Aziz F, Redfield RR, Mandelbrot DA. Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year Perspective. Virology (Auckl) 2019;10:1178122X19840371. [PMID: 30983861 DOI: 10.1177/1178122X19840371] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Chou S. Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. Antiviral Res 2020;176:104711. [PMID: 31940472 DOI: 10.1016/j.antiviral.2020.104711] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
196 López-Aladid R, Guiu A, Mosquera MM, López-Medrano F, Cofán F, Linares L, Torre-Cisneros J, Vidal E, Moreno A, Aguado JM, Cordero E, Martin-Gandul C, Carratalá J, Sabé N, Niubó J, Cervera C, Capón A, Cervilla A, Santos M, Bodro M, Muñoz P, Fariñas MC, Antón A, Aranzamendi M, Montejo M, Pérez-Romero P, Len O, Marcos MÁ. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing. PLoS One 2019;14:e0219701. [PMID: 31318908 DOI: 10.1371/journal.pone.0219701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
197 Märtson AG, Bakker M, Blokzijl H, Verschuuren EAM, Berger SP, Span LFR, van der Werf TS, Alffenaar JC. Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review. BMJ Open 2020;10:e034940. [PMID: 31915177 DOI: 10.1136/bmjopen-2019-034940] [Reference Citation Analysis]
198 Mella A, Mariano F, Dolla C, Gallo E, Manzione AM, Di Vico MC, Cavallo R, De Rosa FG, Costa C, Biancone L. Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients. Biomedicines 2022;10:701. [DOI: 10.3390/biomedicines10030701] [Reference Citation Analysis]
199 Braun B, Fischer D, Laib Sampaio K, Mezger M, Stöhr D, Stanton RJ, Sinzger C. Peptide Derivatives of Platelet-Derived Growth Factor Receptor Alpha Inhibit Cell-Associated Spread of Human Cytomegalovirus. Viruses 2021;13:1780. [PMID: 34578361 DOI: 10.3390/v13091780] [Reference Citation Analysis]
200 Ahlenstiel-Grunow T, Pape L. Virus-specific T cells in pediatric renal transplantation. Pediatr Nephrol 2021;36:789-96. [PMID: 32221706 DOI: 10.1007/s00467-020-04522-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 Ecabert D, Pham C, Pierce BJ, Musick WL, Nguyen DT, Graviss EA. Safety of Valganciclovir 450 mg 3 Times Weekly for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients Requiring Hemodialysis. Open Forum Infect Dis 2021;8:ofab436. [PMID: 34646907 DOI: 10.1093/ofid/ofab436] [Reference Citation Analysis]
202 Diamond DJ, La Rosa C, Chiuppesi F, Contreras H, Dadwal S, Wussow F, Bautista S, Nakamura R, Zaia JA. A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection. Expert Rev Vaccines 2018;17:889-911. [PMID: 30246580 DOI: 10.1080/14760584.2018.1526085] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
203 Shi Y, Lerner AH, Rogers R, Vieira K, Merhi B, Mecadon K, Osband AJ, Bayliss G, Gohh R, Morrissey P, Farmakiotis D. Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients. Prog Transplant 2021;31:368-76. [PMID: 34839729 DOI: 10.1177/15269248211046037] [Reference Citation Analysis]
204 Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edmison B, Boeckh M, Limaye AP. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial. JAMA 2020;323:1378-87. [PMID: 32286644 DOI: 10.1001/jama.2020.3138] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 20.5] [Reference Citation Analysis]
205 Senaweera S, Edwards TC, Kankanala J, Wang Y, Sahani RL, Xie J, Geraghty RJ, Wang Z. Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV). Acta Pharmaceutica Sinica B 2022;12:1671-84. [DOI: 10.1016/j.apsb.2021.08.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Immohr MB, Akhyari P, Böttger C, Mehdiani A, Dalyanoglu H, Westenfeld R, Oehler D, Tudorache I, Aubin H, Lichtenberg A, Boeken U. Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin. Immun Inflamm Dis 2021;9:1554-62. [PMID: 34525263 DOI: 10.1002/iid3.508] [Reference Citation Analysis]
207 Sen P, Wilkie AR, Ji F, Yang Y, Taylor IJ, Velazquez-Palafox M, Vanni EAH, Pesola JM, Fernandez R, Chen H, Morsett LM, Abels ER, Piper M, Lane RJ, Hickman SE, Means TK, Rosenberg ES, Sadreyev RI, Li B, Coen DM, Fishman JA, El Khoury J. Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function. Sci Adv 2020;6:eaax9856. [PMID: 32494628 DOI: 10.1126/sciadv.aax9856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Gürtler N, Hirt-Minkowski P, Brunner SS, König K, Glatz K, Reichenstein D, Bassetti S, Osthoff M. Sodium Polystyrene Sulfonate and Cytomegalovirus-Associated Hemorrhagic Duodenitis: More than Meets the Eye. Am J Case Rep 2018;19:912-6. [PMID: 30072684 DOI: 10.12659/AJCR.910655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
209 Calabrese DR, Chong T, Wang A, Singer JP, Gottschall M, Hays SR, Golden JA, Kukreja J, Lanier LL, Tang Q, Greenland JR. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients. Transplantation 2019;103:493-501. [PMID: 30211828 DOI: 10.1097/TP.0000000000002450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
210 Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Med 2019;45:573-91. [PMID: 30911807 DOI: 10.1007/s00134-019-05597-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
211 Yamada M, Pellett Madan R. CMV as culprit or bystander: The debate continues. Pediatr Transplant 2020;24:e13865. [PMID: 33044777 DOI: 10.1111/petr.13865] [Reference Citation Analysis]
212 Gogesch P, Penner I, Krauter S, Büscher N, Grode L, Aydin I, Plachter B. Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine. Vaccines (Basel) 2019;7:E104. [PMID: 31480520 DOI: 10.3390/vaccines7030104] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
213 Floß N, Dolff S. [Opportunistic infections by human herpes viruses]. Internist (Berl) 2019;60:678-83. [PMID: 31089769 DOI: 10.1007/s00108-019-0615-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
214 Maillard M, Gong L, Nishii R, Yang JJ, Whirl-Carrillo M, Klein TE. PharmGKB summary: acyclovir/ganciclovir pathway. Pharmacogenet Genomics 2022;32:201-8. [PMID: 35665708 DOI: 10.1097/FPC.0000000000000474] [Reference Citation Analysis]
215 Santiago JL, Pérez-Flores I, Sánchez-Pérez L, Moreno de la Higuera MA, Calvo-Romero N, Querol-García J, Culebras E, Urcelay E, Fernández-Pérez C, Sánchez-Fructuoso AI. The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation. Front Immunol 2019;10:2994. [PMID: 31998298 DOI: 10.3389/fimmu.2019.02994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Jorgenson MR, Descourouez JL, Yang DY, Leverson GE, Saddler CM, Smith JA, Safdar N, Mandlebrot DA, Redfield RR. Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Clostridiodes difficile Infection in Renal Transplant Recipients. Ann Pharmacother 2019;53:1020-5. [PMID: 31007034 DOI: 10.1177/1060028019845003] [Reference Citation Analysis]
217 Rogers R, Saharia K, Chandorkar A, Weiss ZF, Vieira K, Koo S, Farmakiotis D. Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events. BMC Infect Dis 2020;20:58. [PMID: 31952516 DOI: 10.1186/s12879-020-4787-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
218 Rezahosseini O, Møller DL, Knudsen AD, Sørensen SS, Perch M, Gustafsson F, Rasmussen A, Ostrowski SR, Nielsen SD. Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review. Front Immunol 2020;11:567715. [PMID: 33178194 DOI: 10.3389/fimmu.2020.567715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
219 Shionoya Y, Kasai H, Terada J, Abe M, Takeda Y, Sakaida E, Tanabe N, Tatsumi K. Cytomegalovirus Pneumonia with Progressive Lung Volume Loss. Am J Case Rep 2018;19:1393-7. [PMID: 30467305 DOI: 10.12659/AJCR.911708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Udomkarnjananun S, Naiyarakseree N, Townamchai N, Surinrat E, Tiankanon K, Banjongjit A, Vanichanan J, Jutivorakool K, Putcharoen O, Suankratay C, Surintrspanont J, Iampenkhae K, Leelahavanichkul A, Wattanatorn S, Apisutimaitri K, Burimsittichai R, Ratchanon S, Nonthasoot B, Sirichindakul B, Praditpornsilpa K, Avihingsanon Y. The first report of kidney transplantation in a human immunodeficiency virus-positive recipient in Thailand and literature review: Encouragement for developing countries in Southeast Asia. SAGE Open Med Case Rep 2021;9:2050313X211024471. [PMID: 34211716 DOI: 10.1177/2050313X211024471] [Reference Citation Analysis]
221 Yu U, Wang X, Zhang X, Wang C, Yang C, Zhou X, Li Y, Huang X, Wen J, Wen F, Liu S. Cytomegalovirus Infection and the Implications of Drug-Resistant Mutations in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Retrospective Study from a Tertiary Hospital in China. Infect Dis Ther 2021;10:1309-22. [PMID: 33966176 DOI: 10.1007/s40121-021-00452-4] [Reference Citation Analysis]
222 Koepf US, Klehr HU, Eis-Huebinger AM, Aldabbagh S, Strassburg CP, Boes D, Lutz P. Suppression of CMV Infection with Letermovir in a Kidney Transplant Patient. Eur J Case Rep Intern Med 2020;7:001622. [PMID: 32665929 DOI: 10.12890/2020_001622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Patel SY, Carbone J, Jolles S. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management. Front Immunol. 2019;10:33. [PMID: 30800120 DOI: 10.3389/fimmu.2019.00033] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 12.7] [Reference Citation Analysis]
224 Aguilar C, Husain S, Lortholary O. Recent advances in understanding and managing infectious diseases in solid organ transplant recipients. F1000Res 2018;7:F1000 Faculty Rev-661. [PMID: 29899970 DOI: 10.12688/f1000research.14262.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
225 Jorgenson MR, Descourouez JL, Wong C, Strayer JR, Parajuli S, Rice JP, Redfield RR, Smith JA, Mandelbrot DA, Saddler CM. Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies. Transpl Infect Dis 2021;:e13586. [PMID: 33595158 DOI: 10.1111/tid.13586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
226 Barten MJ, Baldanti F, Staus A, Hüber CM, Glynou K, Zuckermann A. Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis. Life 2022;12:361. [DOI: 10.3390/life12030361] [Reference Citation Analysis]
227 Chou S, Ercolani RJ, Derakhchan K. Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus. Antiviral Res 2018;157:128-33. [PMID: 30040968 DOI: 10.1016/j.antiviral.2018.07.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
228 Bonavita CM, Cardin RD. Don't Go Breaking My Heart: MCMV as a Model for HCMV-Associated Cardiovascular Diseases. Pathogens 2021;10:619. [PMID: 34069957 DOI: 10.3390/pathogens10050619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients. BMJ Open 2019;9:e024908. [PMID: 30975673 DOI: 10.1136/bmjopen-2018-024908] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
230 Pavlakou P, Papasotiriou M, Ntrinias T, Kourakli A, Bratsiakou A, Goumenos DS, Papachristou E. Case Report: Kidney Transplantation in a Patient With Acquired Agammaglobulinemia and SLE. Issues and Challenges. Front Med (Lausanne) 2021;8:665475. [PMID: 33777986 DOI: 10.3389/fmed.2021.665475] [Reference Citation Analysis]
231 Paulsen G, Cumagun P, Mixon E, Fowler K, Feig D, Shimamura M. Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis. Pediatr Transplant 2019;23:e13382. [PMID: 30786115 DOI: 10.1111/petr.13382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
232 Chou S, Watters M, Sinha R, Kleiboeker S. Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing. Antiviral Res 2021;193:105139. [PMID: 34273445 DOI: 10.1016/j.antiviral.2021.105139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, Biolatti M. Where do we Stand after Decades of Studying Human Cytomegalovirus? Microorganisms 2020;8:E685. [PMID: 32397070 DOI: 10.3390/microorganisms8050685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]